Clare Kahn - 07 Jun 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director
Signature
/s/ by Erin P. Brennan as attorney-in-fact for Clare Kahn
Issuer symbol
SLDB
Transactions as of
07 Jun 2022
Net transactions value
$0
Form type
4
Filing time
09 Jun 2022, 17:10:22 UTC
Next filing
15 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Director Stock Option (Right to Buy) Award $0 +51,000 $0.000000 51,000 07 Jun 2022 Common Stock 51,000 $0.6250 Direct F1
transaction SLDB Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 07 Jun 2022 Common Stock 40,000 $0.6250 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 7, 2022 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.
F2 This option was granted on June 7, 2022 and vests in equal quarterly installments over the 12 month period following the grant date, subject to continued service as a director or consultant.